Trial compares therapies for reducing cardiovascular risk among people with rheumatoid arthritis
People with rheumatoid arthritis are at increased risk of cardiovascular (CV) disease, with studies indicating an approximate 50 percent increase in risk of CV events such as heart attack and stroke. Some immunomodulators—drugs ...
Dec 5, 2022
0
7